589 related articles for article (PubMed ID: 15308739)
21. Transcriptional profiling indicates cAMP-driven reversal of HIV latency in monocytes occurs via transcription factor SP-1.
Moar P; Sushmita K; Kateriya S; Tandon R
Virology; 2020 Mar; 542():40-53. PubMed ID: 32056667
[TBL] [Abstract][Full Text] [Related]
22. Microarray analysis in the HSV-1 latently infected mouse trigeminal ganglion.
Higaki S; Deai T; Fukuda M; Shimomura Y
Cornea; 2004 Nov; 23(8 Suppl):S42-7. PubMed ID: 15448479
[TBL] [Abstract][Full Text] [Related]
23. StpC-based gene therapy targeting latent reservoirs of HIV-1.
Turner LS; Tsygankov AY; Henderson EE
Antiviral Res; 2006 Dec; 72(3):233-41. PubMed ID: 16891001
[TBL] [Abstract][Full Text] [Related]
24. Modeling HIV-1 Latency in Primary T Cells Using a Replication-Competent Virus.
Martins LJ; Bonczkowski P; Spivak AM; De Spiegelaere W; Novis CL; DePaula-Silva AB; Malatinkova E; Trypsteen W; Bosque A; Vanderkerckhove L; Planelles V
AIDS Res Hum Retroviruses; 2016 Feb; 32(2):187-93. PubMed ID: 26171776
[TBL] [Abstract][Full Text] [Related]
25. Apoptosis-induced activation of HIV-1 in latently infected cell lines.
Khan SZ; Hand N; Zeichner SL
Retrovirology; 2015 May; 12():42. PubMed ID: 25980942
[TBL] [Abstract][Full Text] [Related]
26. Tumor suppressor cylindromatosis (CYLD) controls HIV transcription in an NF-κB-dependent manner.
Manganaro L; Pache L; Herrmann T; Marlett J; Hwang Y; Murry J; Miorin L; Ting AT; König R; García-Sastre A; Bushman FD; Chanda SK; Young JA; Fernandez-Sesma A; Simon V
J Virol; 2014 Jul; 88(13):7528-40. PubMed ID: 24760882
[TBL] [Abstract][Full Text] [Related]
27. Underlying mechanisms of HIV-1 latency.
Romani B; Allahbakhshi E
Virus Genes; 2017 Jun; 53(3):329-339. PubMed ID: 28258391
[TBL] [Abstract][Full Text] [Related]
28. A lentiviral vector that activates latent human immunodeficiency virus-1 proviruses by the overexpression of tat and that kills the infected cells.
Macías D; Oya R; Saniger L; Martín F; Luque F
Hum Gene Ther; 2009 Nov; 20(11):1259-68. PubMed ID: 19604078
[TBL] [Abstract][Full Text] [Related]
29. Development of a Novel
Wong ME; Johnson CJ; Hearps AC; Jaworowski A
J Virol; 2021 Sep; 95(19):e0022721. PubMed ID: 34287050
[TBL] [Abstract][Full Text] [Related]
30. Effect of immunosuppression on gene expression in the HSV-1 latently infected mouse trigeminal ganglion.
Higaki S; Gebhardt BM; Lukiw WJ; Thompson HW; Hill JM
Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):1862-9. PubMed ID: 12036991
[TBL] [Abstract][Full Text] [Related]
31. Transcriptome profiles of latently- and reactivated HIV-1 infected primary CD4
Inderbitzin A; Loosli T; Opitz L; Rusert P; Metzner KJ
Front Immunol; 2022; 13():915805. PubMed ID: 36090997
[TBL] [Abstract][Full Text] [Related]
32. Relationship between Measures of HIV Reactivation and Decline of the Latent Reservoir under Latency-Reversing Agents.
Petravic J; Rasmussen TA; Lewin SR; Kent SJ; Davenport MP
J Virol; 2017 May; 91(9):. PubMed ID: 28202759
[TBL] [Abstract][Full Text] [Related]
33. STAT3 Regulates Lytic Activation of Kaposi's Sarcoma-Associated Herpesvirus.
King CA; Li X; Barbachano-Guerrero A; Bhaduri-McIntosh S
J Virol; 2015 Nov; 89(22):11347-55. PubMed ID: 26339061
[TBL] [Abstract][Full Text] [Related]
34. Identification and characterization of differentially expressed mRNAs in HIV type 1-infected human T cells.
Ryo A; Suzuki Y; Arai M; Kondoh N; Wakatsuki T; Hada A; Shuda M; Tanaka K; Sato C; Yamamoto M; Yamamoto N
AIDS Res Hum Retroviruses; 2000 Jul; 16(10):995-1005. PubMed ID: 10890361
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of HIV-1 replication and reactivation from latency by tat transdominant negative mutants in the cysteine rich region.
Caputo A; Grossi MP; Bozzini R; Rossi C; Betti M; Marconi PC; Barbanti-Brodano G; Balboni PG
Gene Ther; 1996 Mar; 3(3):235-45. PubMed ID: 8646555
[TBL] [Abstract][Full Text] [Related]
36. The Wnt Signaling Pathway Is Differentially Expressed during the Bovine Herpesvirus 1 Latency-Reactivation Cycle: Evidence That Two Protein Kinases Associated with Neuronal Survival, Akt3 and BMPR2, Are Expressed at Higher Levels during Latency.
Workman A; Zhu L; Keel BN; Smith TPL; Jones C
J Virol; 2018 Apr; 92(7):. PubMed ID: 29321317
[TBL] [Abstract][Full Text] [Related]
37. Designed transcription activator-like effector proteins efficiently induced the expression of latent HIV-1 in latently infected cells.
Wang X; Wang P; Fu Z; Ji H; Qu X; Zeng H; Zhu X; Deng J; Lu P; Zha S; Song Z; Zhu H
AIDS Res Hum Retroviruses; 2015 Jan; 31(1):98-106. PubMed ID: 25403229
[TBL] [Abstract][Full Text] [Related]
38. Therapeutic doses of irradiation activate viral transcription and induce apoptosis in HIV-1 infected cells.
Iordanskiy S; Van Duyne R; Sampey GC; Woodson CM; Fry K; Saifuddin M; Guo J; Wu Y; Romerio F; Kashanchi F
Virology; 2015 Nov; 485():1-15. PubMed ID: 26184775
[TBL] [Abstract][Full Text] [Related]
39. Modulation of apoptosis and viral latency - an axis to be well understood for successful cure of human immunodeficiency virus.
Timilsina U; Gaur R
J Gen Virol; 2016 Apr; 97(4):813-824. PubMed ID: 26764023
[TBL] [Abstract][Full Text] [Related]
40. A unified concept of HIV latency.
Bagasra O
Expert Opin Biol Ther; 2006 Nov; 6(11):1135-49. PubMed ID: 17049012
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
